Quiet on the insider front: nobody at Verona Pharma plc bought or sold VRNA shares in open-market trades this past year.
Quarter by quarter: No open-market insider buying or selling in the last full quarter. Insiders bought in 0 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Aug 5, 2025 | Cunningham Kenneth | Director | Sell | 10,808 | $13.14 | $142K | SEC |
| Aug 5, 2025 | Deschamps Lisa | Director | Sell | 9,464 | $13.14 | $124K | SEC |
| Aug 5, 2025 | Fisher Andrew | Executive Officer | Sell | 9,584 | $13.14 | $126K | SEC |
| Aug 5, 2025 | Hahn Mark W | CFO | Sell | 208,912 | $13.14 | $2.7M | SEC |
| Aug 5, 2025 | Rickard Kathleen A. | Executive Officer | Sell | 58,336 | $13.14 | $767K | SEC |
| Aug 5, 2025 | ACKERMANN CHRISTINA | Director | Sell | 1,808 | $13.14 | $24K | SEC |
| Aug 5, 2025 | Austwick Michael | Director | Sell | 11,288 | $13.14 | $148K | SEC |
| Aug 5, 2025 | Brady James Aloysius | Director | Sell | 824 | $13.14 | $11K | SEC |
| Aug 5, 2025 | ZACCARDELLI DAVID | CEO | Sell | 208,912 | $13.14 | $2.7M | SEC |
| Aug 5, 2025 | EBSWORTH DAVID R | Director | Sell | 1,904 | $13.14 | $25K | SEC |
| Aug 5, 2025 | Edwards Martin | Director | Sell | 10,808 | $13.14 | $142K | SEC |
| Aug 5, 2025 | SHAH MAHENDRA | Director | Sell | 3,608 | $13.14 | $47K | SEC |
| Aug 5, 2025 | Sinha Vikas | Director | Sell | 4,328 | $13.14 | $57K | SEC |
| Jun 18, 2025 | Fisher Andrew | Executive Officer | Sell | 80,000 | $11.53 | $922K | SEC |
| Jun 13, 2025 | Hahn Mark W | CFO | Sell | 400,000 | $11.40 | $4.6M | SEC |
There were no open-market insider trades in VRNA in the last 12 months. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
No congressional trades in VRNA were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).